期刊文献+

冠心病支架内再狭窄的危险因素分析 被引量:3

Risk factors of in-stent restenosis for coronary heart disease
下载PDF
导出
摘要 目的分析冠心病支架内再狭窄(ISR)的危险因素。方法 102例冠心病患者行经皮冠状动脉内介入治疗,根据术后冠脉造影结果分为ISR组(38例)和非ISR组(64例),分析ISR的危险因素。结果 ISR组中吸烟、糖尿病、心肌梗死、尿酸、总胆固醇、脂蛋白a及术前狭窄程度均高于非ISR组(P<0.01或0.05),总胆红素水平低于非ISR组(P<0.05)。Logistic回归分析显示吸烟、糖尿病、心肌梗死、总胆红素、尿酸及术前狭窄程度为ISR的独立危险因素(P<0.05)。结论冠心病患者发生ISR与吸烟、糖尿病、心肌梗死、总胆红素、尿酸及术前狭窄程度有关。 Objective To analyze the risk factors of in-stent restenosis(ISR) in patients with coronary heart disease(CHD). Based on postoperative coronary angiography results, 102 CHD patients undergoing percutaneous coronary Methodsintervention were divided into ISR group(n=38) and non-ISR group(n=64) and the risk factors were then analyzed. Results Compared with non-ISR group, smoking, diabetes mellitus, myocardial infarction, uric acid, total cholesterol, lipoprotein a and preoperative stenosis were significantly higher(P〈0.01 or 0.05), while total bilirubin level was lower(P〈0.05) in ISR group. Logistic regression analysis showed that diabetes mellitus, myocardial infarction, total bilirubin, uric acid and preoperative stenosis were independent risk factors for ISR(P〈0.05). Conclusion ISR is related to smoking, diabetes mellitus, myocardial infarction, total bilirubin, uric acid, and preoperative stenosis in CHD patients.
作者 冯明瑞 李庆军 吴庆法 李泽林 李娟 FENG Ming-rui;LI Qing-jun;WU Qing-fa;LI Ze-lin;LI Juan(Department of Cardiology,Zhanjiang Central People's Hospital,Zhanjiang 524037,China)
出处 《广东医科大学学报》 2018年第4期400-403,共4页 Journal of Guangdong Medical University
基金 湛江市科技计划项目(No.2016B101)
关键词 冠心病 支架内再狭窄 危险因素 coronary heart disease in-stent restenosis risk factors
  • 相关文献

参考文献8

二级参考文献95

  • 1李博,朱平先,吴清华.64排128层螺旋CT在冠状动脉与支架术后狭窄诊断中的应用价值[J].中华临床医师杂志(电子版),2012,6(20):167-169. 被引量:25
  • 2金泽宁,陈韵岱,吕树铮,宋现涛,朱华刚,李红.冠心病合并糖尿病患者金属裸支架置入术后再狭窄的临床和造影预测因素[J].中华心血管病杂志,2006,34(12):1093-1096. 被引量:11
  • 3Sondergaard HM, Botker HZ, Bottcher M, et al. Percutaneous coronary intervention in patients with diabetes mellitus[J]. Ugeskr Laeger,2003,165(2) :111 - 115.
  • 4Mckenna K T,Maas F,Mc Eniery PT,et al. Coronary risk tactor status after percutaneous translumininal coronary angioplasty[J]. Heart Lung,1995,24(3) :207 - 212.
  • 5雷寒 陈玉国 马康华.冠状动脉再狭窄的病理生理与临床评价[A].见:马长生著.介入心脏病学[C].人民卫生出版社,1999,9.64-71.
  • 6Wizemann TM, Pardue ML.Exploring the biological contributions to human health: does sex matter? [J]. J Womens Health Gend Based Med, 2001,10 ( 5 ) :433-439.
  • 7中国疾病预防控制中心.全国疾病监测系统死因监测数据集(2004-2011)[M].北京:军事医学出版社,2005-2012.
  • 8Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart dis- ease and stroke statistics-2014 update: a report from the American Heart Association[J]. Circulation, 2014, 129(3): 399-410.
  • 9Xie J, Wu EQ,Zheng ZJ,et al. Patient-reposed health status in coronary heart disease in the United States:age, sex, racial, and eth- nic differences [ J ].Circulation, 2008,118 (5) : 491-497.
  • 10Mendelsohn ME.Protective effects of estrogen on the cardiovascular system[J ].Am J Cardiol,2002,89(Suppl):12E-18E.

共引文献103

同被引文献28

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部